Table 3Unadjusted Changes in Mean Scores of Domains of the KDQOL-36 Throughout the Study Period by Intervention Group (ITT Analysis)a

Domains and assessment pointsFTF PM groupOnline PM groupTextbook-only group
Change in mean score ± SE; 95% CIP valuebChange in mean score ± SE; 95% CIP valuebChange in mean score ± SE; 95% CIP value
EKD score
 12 mo compared with baseline9.2 ± 4.8; −0.3 to 18.7.067.7 ± 4.7; −1.6 to 17.0.10−4.6 ± 4.1; −12.7 to 3.5.26
 18 mo compared with 12 mo−2.7 ± 4.6; −11.8 to 6.4.562.1 ± 4.8; −7.5 to 11.7.663.5 ± 4.3; −5.0 to 12.0.42
 18 mo compared with baseline6.5 ± 5.3; −4.0 to 17.0.229.8 ± 4.8; 0.2-19.4 .04 −1.1 ± 4.27; −9.6 to 7.4.80
BKD score
 12 mo compared with baseline1.2 ± 5.7; −10.2 to 12.6.8411.7 ± 5.7; 0.4-23.0 .04 −9.8 ± 6.25; −22.2 to 2.6.12
 18 mo compared with 12 mo6.3 ± 5.8; −5.2 to 17.8.281.7 ± 6.6; −11.5 to 14.9.806.7 ± 7.3; −7.8 to 21.2.36
 18 mo compared with baseline7.5 ± 5.9; −4.3 to 19.3.2113.4 ± 6.2; 1.0-25.8 .03 −3.1 ± 6.8; −16.7 to 10.5.65
SPKD score
 12 mo compared with baseline8.3 ± 3.4; 1.5-15.1 .01 9.0 ± 3.6; 1.9-16.1 .01 −4.1 ± 3; −10.1 to 1.9.18
 18 mo compared with 12 mo−4.9 ± 3.4; −11.7 to 1.9.15−1.0 ± 3.0; −7.0 to 4.9.740.6 ± 3.6; −6.5 to 7.7.87
 18 mo compared with baseline3.4 ± 3.9; −4.3 to 11.0.388.0 ± 3.6; 0.8-15.2 .03 −3.5 ± 2.9; −9.2 to 2.2.23
SF-12 PCS score
 12 mo compared with baseline1.9 ± 2.0; −2.0 to 5.8.337.8 ± 1.9; 4.1-11.6 .0001 −4.4 ± 2.3; −9.1 to 0.3.06
 18 mo compared with 12 mo−0.8 ± 1.9; −4.7 to 3.1.68−2.0 ± 2.1; −6.2 to 2.2.352.5 ± 2.5; −2.5 to 7.5.33
 18 mo compared with baseline1.1 ± 2.0; −2.8 to 5.0.575.8 ± 2.0; 1.8-9.8 .005 −1.9 ± 2.5; −6.8 to 3.0.44
SF-12 MCS score
 12 mo compared with baseline6.2 ± 2.2; 1.8-10.6 .006 6.5 ± 2.1; 2.4-10.6 .002 −1.3 ± 2.0; −5.3 to 2.7.52
 18 mo compared with 12 mo−2 ± 2.2; −6.5 to 2.5.371.2 ± 2.0; −2.8 to 5.2.555 ± 2.5; −0.09 to 9.9.05
 18 mo compared with baseline4.2 ± 2.2; −0.2 to 8.6.067.7 ± 2.0; 3.7-11.7 .0002 3.7 ± 1.9; −0.2 to 7.6.06

Abbreviations: BKD, Burden of Kidney Disease; EKD, Effects of Kidney Disease; FTF, face to face; ITT, intention to treat; KDQOL-36, Kidney Disease Quality of Life-36; MCS, Mental Composite Summary; PCS, Physical Composite Summary; PM, peer mentoring; SF-12, Short Form-12; SPKD, Symptoms and Problems of Kidney Disease.

aHigher score indicates better outcome; negative change in score indicates worse outcome over time.

bBold font denotes statistically significant P values.

From: Comparing Three Ways to Improve Quality of Life for Patients with Kidney Disease and Their Caregivers

Cover of Comparing Three Ways to Improve Quality of Life for Patients with Kidney Disease and Their Caregivers
Comparing Three Ways to Improve Quality of Life for Patients with Kidney Disease and Their Caregivers [Internet].
Ghahramani N, Kraschnewski JL, Lengerich EJ, et al.
Copyright © 2020. Pennsylvania State University Hershey Medical Center. All Rights Reserved.

This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License which permits noncommercial use and distribution provided the original author(s) and source are credited. (See https://creativecommons.org/licenses/by-nc-nd/4.0/

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.